Multi-drug-resistant tuberculosis overview

Multi-drug-resistant tuberculosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multi-drug-resistant tuberculosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Multi-drug-resistant tuberculosis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multi-drug-resistant tuberculosis overview
CDC on Multi-drug-resistant tuberculosis overview
Multi-drug-resistant tuberculosis overview in the news
Blogs on Multi-drug-resistant tuberculosis overview
Directions to Hospitals Treating Multi-drug-resistant tuberculosis
Risk calculators and risk factors for Multi-drug-resistant tuberculosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Multi-drug resistant tuberculosis (MDR-TB) is defined as TB that is resistant at least to isoniazid (INH) and rifampicin (RMP). Isolates that are multiply-resistant to any other combination of anti-TB drugs but not to INH and RMP are not classed as MDR-TB.